Diagnostic Performance and Quantitative Analysis of [18F]FET PET in Brain Tumours
ConditionBrain Tumors
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele
About this trial
This is a retrospective study encompassing all \[18F\]FET PET scans performed at our centre. By analysing both static and dynamic scans, conducting in-depth kinetic modelling, and comparing quantitative parameters across different tumour types and clinical contexts, the study aims to determine the true diagnostic value of \[18F\]FET PET in everyday clinical practice. The ultimate goal is to identify imaging biomarkers useful for improving tumour characterisation and distinguishing recurrence from post-treatment changes, thereby strengthening the role of \[18F\]FET PET in modern neuro-oncology.
Eligibility criteria
Qualifiers
Patients who underwent a brain PET/CT or PET/MRI scan with [18F]FET for clinical reasons during the study period.
Age ≥ 18 years.
Indication for the scan related to diagnosis, grading, assessment of treatment response or suspected recurrence of any brain tumour (primary or metastatic).
Availability of the corresponding static and dynamic images.
Disqualifiers
. Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Not listed
Trial groups
69 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov